Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,665,739
-
Share change
-
-2,045,073
-
Total reported value
-
$19,222,238
-
Price per share
-
$0.45
-
Number of holders
-
48
-
Value change
-
-$1,385,022
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q4 2022
As of 31 Dec 2022,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,665,739 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Nantahala Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, Sio Capital Management, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Aisling Capital Management LP.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.